Ankit Mahadevia is the founder of Spero Therapeutics. Spero Therapeutics has raised $250M in total funding. Latest round: Series A.
Ankit Mahadevia is the co-founder and former CEO of Spero Therapeutics, a biopharmaceutical company specializing in infectious disease therapeutics. He led the company through multiple funding rounds, including a $30.4 million Series A, and a $500 million collaboration with Biogen. He resigned from Spero Therapeutics effective January 30, 2026.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide